A previous study found an association between prolactin concentrations and CYP2D6 polymorphisms in 47 pediatric patients with autism spectrum disorders or conduct disorders receiving risperidone, aged 10–19, showing higher prolactin levels in patients with reduced or no activity of CYP2D6 versus normal metabolizers [50]. The gene discussed is CYP2D6; the disease is conduct disorder.